Mark Talamonti to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Mark Talamonti has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.031
-
Pancreatic cancer and FOLFIRINOX: a new era and new questions. Cancer Med. 2015 Jun; 4(6):853-63.
Score: 0.031
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.